Role of prostaglandin E2 in tissue repair and regeneration

Theranostics. 2021 Aug 13;11(18):8836-8854. doi: 10.7150/thno.63396. eCollection 2021.

Abstract

Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following injury for its capabilities such as activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding how PGE2 modulates tissue regeneration and then exploring how to elevate the regenerative efficiency of PGE2 will provide key insights into the tissue repair and regeneration processes by PGE2. In this review, we summarized the application of PGE2 to guide the regeneration of different tissues, including skin, heart, liver, kidney, intestine, bone, skeletal muscle, and hematopoietic stem cell regeneration. Moreover, we introduced PGE2-based therapeutic strategies to accelerate the recovery of impaired tissue or organs, including 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors boosting endogenous PGE2 levels and biomaterial scaffolds to control PGE2 release.

Keywords: Inflammation; Prostaglandin E2; Regeneration; Stem cell; Tissue repair.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Dinoprostone / metabolism
  • Dinoprostone / physiology*
  • Humans
  • Regeneration / physiology*
  • Signal Transduction / drug effects
  • Wound Healing / physiology*

Substances

  • Dinoprostone